Elevated ROCK1 and/or ROCK2 expression was associated with shorter survival in human pancreatic cancer patients, while conditional ROCK activation in KrasG12D‐driven PDAC mice was sufficient to accelerate mortality. The gene discussed is ROCK1; the disease is pancreatic neoplasm.